Organizers launch a fresh approach across many platforms
(NORWALK, Conn., February 21, 2012) – With an established history as the largest annual industry exhibit for pharma/biopharma manufacturers, INTERPHEX enters its 2012 event with a new platform of offerings, according to the event’s organizers and professional advisory board. These innovations will be launched at this year’s show, at New York’s Javits Center on May 1-3, 2012.
Exhibitors and attendees will find not only more than 650 suppliers and 1,000 product lines filling the floor zones of Facilities, Manufacturing & Packaging, Automation Systems & Controls and Sourcing & Services, but also a reformatted conference program which reflects the cross functional team approach to bringing products successfully to market. In addition, there are technical workshops, keynote presentations, case study-focused floor tours, and special Thursday sessions open to all badgeholders.
“We’ve taken the energy from last year’s boost in attendance and built on it in a big way for INTERPHEX 2012,” said Bob Stewart, Industry Vice President. “We’ve revitalized and grown the conference program to 52 content rich topics over three days, brought in more senior-level speakers and opened up a portion of the conference program to all badgeholders – in addition to bringing back popular features and presentations. This is INTERPHEX at a whole new level.”
Conference Component Tracks the Drug Development Process
The 2012 conference topics will be presented in five tracks targeted to cover the latest achievements in each stage of manufacturing as a drug moves to market: Regulatory Quality Assurance/Quality Control, Product Development, Facility & Process Design, Manufacturing & Packaging, and Supply Chain.
This new approach has been developed by the 2012 Advisory Board, a volunteer panel of industry professionals whose combined experience represents the spectrum of pharmaceutical and biopharmaceutical manufacturing. Speakers include experts from the U.S. Food & Drug Administration, a principle engineer from the National Aeronautics and Space Administration, a microbiologist from the U.S. Dept. of Commerce, and a higher contingent of representatives from international firms.
“The speakers are some of the best and brightest, and the tracks address the practical issues manufacturers face at every stage of the process, from resource procurement and regulatory review to successful commercialization,” said R.J. Palermo, Vice President of Strategic Initiatives. “We’ve also added a higher number of case studies, delivering real-world solutions presented by those involved in making them happen.”
The case study approach has also been extended to the Integrated Project Services (IPS)-led exhibit technology floor tours, first launched in 2008, and with pre-registration, the tours are now free to all badgeholders. This year there will be three tours focusing on advanced aseptic, biologics and oral solid dosage form manufacturing, each will be preceded by a case study, including The Role of CMOs in Supporting Global Vaccine Production Needs: A Case Study on Brazil Fill Finish; Next Gen Biomanufacturing: Developing the Manufacturing Facility of the Future; and Should it be Scale-Up or Scale Out…Bigger is not Always Better or Faster.
Keynotes, Special Thursday Sessions and Technical Workshops Open to All
The Thursday schedule includes the following special presentations:
- Practical Applications of Statistical Methods Under 2011 FDA Process Validation Guidance: Abe Germansderfer, Associate Director, Gilead Sciences, Inc.
- Making it in Massachusetts –A Small Company’s Road to the CMO Market: Glenn Alto, President and CEO, Pharmalucence, Inc. and Edward J. Connolly, Chief Operating Officer, Pharmalucence, Inc.
- Development of Novel CR Formulation Mitigating Dose Dumping & Misuse: Shams Rustom, M.Pharm, RPh., Senior Director, Product Development & Manufacturing, Labopharm.
The conference will feature three keynote presentations:
- What the New Bio/Pharma Business Model Means for CMOs and CROs: Jim Miller, President, PharmSource.
- Control, Capability, and Capacity: Elements Assuring a Reliable Drug Supply: Jeffrey C. Baker, Ph.D., Deputy Director, Office of Biotechnology Products, Center for Drug Evaluation & Research, FDA.
- Creating Innovative Cold Chain Solutions For Your Pharmaceutical and Biopharmaceutical Products: Richard Smith, Director, Life Sciences & Specialty Services, FedEx.
The conference program will also feature eight 45-minute Technical Workshops, led by Bosch, EMD Millipore Corporation, Fette Compacting America, GE Healthcare, Glatt Air Techniques, Pall Life Sciences, STERIS, and Thermo Fisher Scientific. The Thursday sessions, keynote presentations, Floor Tours, and Technical Workshops will be open to all badge holders, welcoming both conference and exhibits-only attendees.
Event to Feature 2012 ISPE Facility of the Year Awards (FOYA) Category Winners
This year marks ISPE’s 15th year as the major sponsor of INTERPHEX, and both organizations will join with Pharmaceutical Processing magazine to showcase five Category Winners and one Special Recognition award winner in the eighth annual Facility of the Year Awards (FOYA) program, in a special winners’ center. The award categories and winning companies are:
- Sustainability: Chiesi Farmaceutici S.p.A., for its Chiesi Farmaceutici Research and Development Centre facility in Parma, Italy.
- Project Execution: Eisai Pharmatechnology & Manufacturing Pvt. Ltd., for its Eisai Knowledge Centre facility in Andhra Pradesh, India.
- Facility Integration: Merck & Co., Inc., for its Merck Vaccine Bulk Manufacturing Facility (VBF) Program of Projects in Durham, North Carolina USA.
- Equipment Innovation: Rentschler Biotechnologie GmbH, for its REX III manufacturing facility in Laupheim, Germany.
- Operational Excellence: Roche Diagnostics GmbH, for its TP Expand project in Penzberg, Germany
- Special Recognition for Novel Collaboration: National Institute for Bioprocessing Research and Training (NIBRT), for its New Greenfield facility in Dublin, Ireland.
Representatives from each firm will be available to discuss their projects, in the only joint appearance the winners will make apart from the ISPE Annual Meeting in November 2012, when one category winner will be named Overall Winner.
Additional Benefits and Events
Other event benefits include the Outsourcing One-on-One Meetings, sponsored by Contract Pharma, which will match attendees with sourcing needs together with contract manufacturers and other service providers in a staffed meeting center with private meeting rooms. Eligible attendees will be able to book meetings in advance through registration. The entire event will lead off Tuesday, May 1 with the Opening Night Reception, followed on Wednesday, May 2 with a Women’s Networking Reception; both are open to all attendees and exhibitors. There will also be a VIP Lounge and ISPE members will have access to the ISPE Member Lounge.
More Details and Connections
Details on registration, conference packages, group and ISPE member discounts can be found at www.INTERPHEX.com/press and event news is available via Facebook, Twitter and LinkedIn.
INTERPHEX USA is the world’s most trusted forum for leading-edge technology, education, and sourcing of products and services that improve manufacturing and supply chain performance for pharmaceutical, biologic, generic and service provider professionals. It brings pharmaceutical and biotechnology professionals together with suppliers through a unique combination of conference, exhibition, workshops, partnering opportunities, and networking events. INTERPHEX 2012 will be held May 1-3, 2012 at the Javits Center in New York City.
INTERPHEX is produced by Reed Exhibitions, which manages more than 460 trade events annually worldwide and is a member of the Reed Elsevier Group plc, a world-leading provider of information-driven services and solutions. For information, visit www.INTERPHEX.com and follow INTERPHEX on Facebook, LinkedIn and Twitter (@INTERPHEX)